Skelley JW - Search Results

1

Evaluation of Pharmacist-led Telehealth Medicare Annual Wellness Visits to Satisfy Quality Metrics and USPSTF Recommendations After Implementation of a Post-Visit Follow-Up Protocol.

Skelley JW, Rogers CJ, Gonzalez E, Kim S, York AL, Duncan H, Morris F. Skelley JW, et al. J Pharm Pract. 2024 Oct 30:8971900241296638. doi: 10.1177/08971900241296638. Online ahead of print. J Pharm Pract. 2024. PMID: 39475481

2

Clinical and Financial Outcomes of a Pilot Pharmacist-Led Continuous Glucose Monitoring Clinic.

Ballard L, York AL, Skelley JW, Sims M. Ballard L, et al. Among authors: skelley jw. Innov Pharm. 2024 Mar 18;15(1):10.24926/iip.v15i1.6081. doi: 10.24926/iip.v15i1.6081. eCollection 2024. Innov Pharm. 2024. PMID: 38779111 Free PMC article.

3

Peer review and publication delay.

Fernandez-Llimos F; Pharmacy Practice 2018 peer reviewers. Fernandez-Llimos F, et al. Pharm Pract (Granada). 2019 Jan-Mar;17(1):1502. doi: 10.18549/PharmPract.2019.1.1502. Epub 2019 Mar 21. Pharm Pract (Granada). 2019. PMID: 31015883 Free PMC article.

4

Role of a Pharmacist in Postdischarge Care for Patients With Kidney Disease: A Scoping Review.

Manis MM, Skelley JW, Read JB, Maxson R, O'Hagan E, Wallace JL, Siew ED, Barreto EF, Silver SA, Kane-Gill SL, Neyra JA. Manis MM, et al. Among authors: skelley jw. Ann Pharmacother. 2024 Dec;58(12):1238-1248. doi: 10.1177/10600280241240409. Epub 2024 Apr 2. Ann Pharmacother. 2024. PMID: 38563565 Review.

5

Reprint of: Impact of a pharmacist-driven COPD clinic on outcomes related to COPD in a federally qualified health center.

Glover LH, Skelley JW, Cimino LH, Berry RB. Glover LH, et al. Among authors: skelley jw. J Am Pharm Assoc (2003). 2024 Jul-Aug;64(4S):102170. doi: 10.1016/j.japh.2024.102170. Epub 2024 Aug 11. J Am Pharm Assoc (2003). 2024. PMID: 39140904

6

Impact of a pharmacist-driven COPD clinic on outcomes related to COPD in a federally qualified health center.

Glover LH, Skelley JW, Cimino LH, Berry RB. Glover LH, et al. Among authors: skelley jw. J Am Pharm Assoc (2003). 2024 Mar-Apr;64(2):512-516. doi: 10.1016/j.japh.2023.11.020. Epub 2023 Nov 28. J Am Pharm Assoc (2003). 2024. PMID: 38030076

7

The impact of tirzepatide and glucagon-like peptide 1 receptor agonists on oral hormonal contraception.

Skelley JW, Swearengin K, York AL, Glover LH. Skelley JW, et al. J Am Pharm Assoc (2003). 2024 Jan-Feb;64(1):204-211.e4. doi: 10.1016/j.japh.2023.10.037. Epub 2023 Nov 7. J Am Pharm Assoc (2003). 2024. PMID: 37940101 Review.

8

Strategies for overcoming therapeutic inertia in type 2 diabetes: A systematic review and meta-analysis.

Powell RE, Zaccardi F, Beebe C, Chen XM, Crawford A, Cuddeback J, Gabbay RA, Kissela L, Litchman ML, Mehta R, Meneghini L, Pantalone KM, Rajpathak S, Scribner P, Skelley JW, Khunti K. Powell RE, et al. Among authors: skelley jw. Diabetes Obes Metab. 2021 Sep;23(9):2137-2154. doi: 10.1111/dom.14455. Epub 2021 Jun 27. Diabetes Obes Metab. 2021. PMID: 34180129

9

Frontline perspective on credentialing and privileging of ambulatory care pharmacists.

Weber ZA, Skelley JW, Riche DM, Bryant Shilliday B, Cavanaugh JJ, Foster K. Weber ZA, et al. Among authors: skelley jw. Int J Pharm Pract. 2020 Aug;28(4):408-412. doi: 10.1111/ijpp.12619. Epub 2020 Mar 23. Int J Pharm Pract. 2020. PMID: 32202353

10

Use of cannabidiol in anxiety and anxiety-related disorders.

Skelley JW, Deas CM, Curren Z, Ennis J. Skelley JW, et al. J Am Pharm Assoc (2003). 2020 Jan-Feb;60(1):253-261. doi: 10.1016/j.japh.2019.11.008. Epub 2019 Dec 19. J Am Pharm Assoc (2003). 2020. PMID: 31866386

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters